24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825

Medical Disorders
Resources
Basic InformationLookupsLatest News
Money Worries Around Food May Spur MigrainesCould Antibacterial Triclosan Weaken Women's Bones?Buyer Beware: Many Stem Cell Clinics Lack Docs Trained in TreatmentsHealth Tip: Treating a Dog BiteVets With PTSD Face Higher Odds for Early Death From Multiple CausesFDA Expands Cystic Fibrosis Treatment Approval to Children Ages 6 to 12AHA News: Half of U.S. Adults Should Monitor Blood Pressure at Home, Study SaysWidely Prescribed Class of Meds Might Raise Dementia Risk9/11 Dust Linked to Prostate Cancer in First RespondersOcean Swimming Causes Skin Changes: StudyNew Drug Combats Leading Cause of DwarfismAHA News: What Migraine Sufferers Need to Know About Stroke RiskNorovirus Fears Stir Recall of Frozen BlackberriesFlying Insects in Hospitals Carry 'Superbug' GermsU.S. Cases of Infant Gut Illness Plummet After Vaccine IntroducedAHA News: This Faulty Gene May Help Predict Heart Muscle DiseaseCell Mapping Provides New Insights About AsthmaHealth Tip: Recognizing Balance DisordersThe Safer Way to Ease Post-Surgical PainLong Work Hours Tied to Higher Odds for StrokeSudden Death Can Occur Even in Well-Controlled EpilepsyStatins May Lower Risk of Stroke After Cancer RadiotherapyExperimental Drug Shows Early Promise Against Sickle Cell DiseaseFitness in Middle Age Cuts Men's Odds for COPD LaterVitamin D Supplements May Not Help Your HeartHow to Head Off a Pain in the NeckSprouts Supermarkets Recalls Frozen Spinach Due to Listeria FearsA-Fib Can Raise Dementia Risk, Even in Absence of StrokeAnother Climate Change Threat: More 'Flesh-Eating' Bacteria?Heading to Europe This Summer? Get Your Measles ShotAiling Heart Can Speed the Brain's Decline, Study FindsHealth Tip: Preventing GlaucomaHead Injuries Tied to Motorized Scooters Are Rising: StudyOverweight Kids Are at Risk for High Blood PressureHot Water Soak May Help Ease Poor Leg CirculationHealth Tip: Understanding RosaceaHealth Tip: Causes of Swollen Lymph NodesAHA News: Study Provides Rare Look at Stroke Risk, Survival Among American IndiansCDC Opens Emergency Operations Center for Congo Ebola OutbreakScared Safe: Pics of Sun's Damage to Face Boost Sunscreen UseNo Needle Prick: Laser-Based Test Hunts Stray Melanoma Cells in BloodBats Are Biggest Rabies Danger, CDC SaysEmgality Receives First FDA Approval for Treating Cluster HeadacheZerbaxa Approved for Hospital-Acquired Bacterial PneumoniaBlood From Previously Pregnant Women Is Safe for Donation: StudyStudy Refutes Notion That People on Warfarin Shouldn't Eat Leafy GreensCancer Survivors Predicted to Top 22 Million by 2030Your Guide to a Healthier Home for Better Asthma ControlHigh Blood Pressure at Doctor's Office May Be More Dangerous Than SuspectedAHA News: 3 Simple Steps Could Save 94 Million Lives Worldwide
Questions and AnswersLinks
Related Topics

Diabetes

Lungs, Hearts Infected With Hepatitis C Still OK for Transplant

HealthDay News
by By Dennis ThompsonHealthDay Reporter
Updated: Apr 3rd 2019

new article illustration

WEDNESDAY, April 3, 2019 (HealthDay News) -- Patients in dire need of an organ transplant can safely receive a new heart or lung from donors who have hepatitis C, a new clinical trial has shown.

By swiftly administering powerful antiviral drugs, doctors can prevent the organ recipient from contracting hepatitis C following their transplant, said lead researcher Dr. Ann Woolley. She's an infectious disease doctor with Brigham and Women's Hospital in Boston.

None of the first 35 transplant patients enrolled in the trial program have any detectable levels of hepatitis C virus in their bloodstream after at least six months, Woolley said. Additionally, she said all of their new organs are in fine working order.

The breakthrough strategy could increase the number of potential organs available to patients by 20% to 25%, Woolley said.

"We saw in our center alone that of all the transplants we've done in the past two years, over a third of them have been from hepatitis C-positive donors," Woolley said.

Although the number of organ transplants in the United States has increased by 20% over the past five years, it's estimated that about 1,000 people die annually waiting for a new heart or lung, the researchers said in background notes.

Organs typically are washed out as much as possible before transplant, but there's always a microscopic amount of donor blood within them, Woolley said. Within that blood lies the risk of hepatitis C infection.

"The virus doesn't come in the organ itself. It's not in the heart or in the lung. It comes with the blood from the donor within the organ," Woolley explained.

More than 4 out of 5 people who received organs in the past from hepatitis C-positive donors wound up with a chronic infection themselves, researchers said in background notes. This not only threatened the health of their livers, but in some cases damaged their new organ.

The new transplant protocol calls for recipients to receive hepatitis C antivirals starting a few hours after leaving the operating room, Woolley said. Rather than wait for the patient to develop an infection, doctors instead head hep C off at the pass.

"It blocks the viral replication from occurring," Woolley said. "The virus needs time to get to the liver to set up shop and replicate there. By starting treatment right away, all the recipient is exposed to is a very low level of virus from the donor."

Since the recipients are exposed to only a tiny amount of virus, they don't have to undergo a full 12-week regimen of antivirals like people who've had chronic hepatitis C for months or years, Woolley said.

Instead, people who get a hep C-positive organ only have to take a four-week course of antivirals costing about $25,000, Woolley said.

The report, published April 3 online in the New England Journal of Medicine, said that 44 patients were initially enrolled in the study, including eight people who received new hearts and 36 who received new lungs.

But given the study's success, enrollment has continued and a total of 69 people have received hepatitis C-positive organs to date.

About 42 of the initial 44 patients in the program had a detectable hepatitis C viral load immediately following transplant, but the amount of virus declined to the point of being undetectable within about two weeks, the report said.

Woolley believes that this could become a new standard for transplants, particularly if the heavy cost of antiviral drugs continues to decrease the longer they are on the market.

Dr. Emily Blumberg, director of transplant infectious diseases at Penn Medicine, said the new protocol "has the potential to be a big advance, because currently there is a pretty sizeable number of individuals who have hepatitis C who are potential organ donors."

The drug regimen was not associated with any toxic effects, but doctors will have to be careful to track potential drug interactions, Blumberg said. For example, the antivirals can have interactions with statins and with certain heart medications.

"Most of the drug interactions are manageable, and we think the sooner you can start the medication, the better the potential for clearing the infection faster," said Blumberg, who wrote an editorial accompanying the study.

Doctors will need to keep tracking the progress of these patients to show that the safety of the process is long-term, she said.

The next step to making this standard care is to make sure that insurance companies will cover the cost of the antiviral treatment, Blumberg said.

"We need to be able to assure patients they will have real access to the drugs," Blumberg said. "Some companies are committed to providing the treatment, and some are not."

More information

The United Network for Organ Sharing has more about transplant statistics.